HomeCONGRESSInternational Congresses

International Congresses

View Category
Day 2

SAVOR-TIMI 53: Saxagliptin showed no cardiovascular benefit

The cardiovascular safety and efficacy of some hypoglycemic including saxagliptin (Onglyza), an inhibitor of dipeptidyl peptidase 4...
solaci -
Learn More
Day 2

ASSURE: Inducing Apo A-1 agent failed to reduce atherosclerotic plaque

Induction apoA-1  synthesis is a new therapeutic approach for the functional HDL particles generation. The RVX-208 induces...
solaci -
Learn More
Day 2

COMPARE: Losartan shows promising results in patients with Marfan syndrome

Patients with Marfan syndrome (connective tissue disorder) are more susceptible to aortic dilation and consequently dissection and...
solaci -
Learn More
Day 2

EXAMINE: The alogliptin is safe for treating type 2 diabetes in patients with a recent history of acute coronary syndrome.

Type 2 diabetes is associated both microvascular and macrovascular disease. Adequate glycemic control can reduce the risk...
solaci -
Learn More
EuroPCR 2015.

EuroPCR 2015.

Find the coverage of the Congress- May 19 - 22 at the Palais des Congrès in Paris,...
solaci -
Learn More
ACC.15.

ACC.15.

American College of Cardiology Annual Congress - March 14 to 16 - San Diego, CA (USA) If you...
solaci -
Learn More
AHA 2014.

AHA 2014.

November 15 to 19 in Chicago, USA. As usual, find the best presentations of the event courtesy...
solaci -
Learn More
Day 1

TCT 2014 – Poster Presentation | Inspiron Registry: Safety and efficacy in a group of patients at very high risk.

TCT2014-09-14
solaci -
Learn More